Franz Masseli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Franz Masseli has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Wolfgang Schiller
Department of Cardiac Surgery, University of Bonn, Bonn, Germany
5 shared publications A. Elsässer
Kerckhoff-Heart-Center, Dept. of Cardiology, Bad Nauheim, Germany
3 shared publications- Andreas Rolf
Department of Cardiology, Justus Liebig University Giessen, Bad Nauheim, Germany
3 shared publications Christian Hamm
2 shared publicationsChristian Troidl
2 shared publicationsHelge Möllmann
2 shared publications
Latest Publications
- Open Access
- 12 February 2024
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 57 (3) , 512-519
Blood group AB is associated with reduced blood loss but also elevated cardiovascular mortality in aortocoronary bypass surgery
Patient blood group (BG) is predictive for von-Willebrand-factor (VWF) and Factor VIII variation. The clinical impact of this ABO-effect on blood loss, cardiovascular complications and outcome has been described for several patient cohorts. The aim of this study was to investigate the impact of patient BG on blood loss and outcome after coronary artery bypass surgery (CABG). Patient records, intraoperative data and perioperative transfusion records of 5713 patients receiving an on-pump CABG procedure between 05/2004 and 12/2018 were analyzed. A logistic regression model for death due to perioperative myocardial ischaemia (PMI) was developed from initially 24 variables by using an univariate and multivariate selection process. BG AB patients required less blood transfusions as compared to the other blood groups, especially in case of emergency operations. However, BG AB patients also had a higher mortality which was due to secondary cardiovascular complications. The impact of blood type on the rate of cardiovascular mortality was confirmed in the logistic regression model. BG AB patients have a worse outcome after CABG surgery due to an increased incidence of fatal cardiovascular complications. As perioperative myocardial ischemia due to graft occlusion appears to be the most likely explanation, stricter anticoagulation for BG AB patients should be discussed.
- 12 February 2024
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 57 (3) , 512-519
Open AccessBlood group AB is associated with reduced blood loss but also elevated cardiovascular mortality in aortocoronary bypass surgery
Patient blood group (BG) is predictive for von-Willebrand-factor (VWF) and Factor VIII variation. The clinical impact of this ABO-effect on blood loss, cardiovascular complications and outcome has been described for several patient cohorts. The aim of this study was to investigate the impact of patient BG on blood loss and outcome after coronary artery bypass surgery (CABG). Patient records, intraoperative data and perioperative transfusion records of 5713 patients receiving an on-pump CABG procedure between 05/2004 and 12/2018 were analyzed. A logistic regression model for death due to perioperative myocardial ischaemia (PMI) was developed from initially 24 variables by using an univariate and multivariate selection process. BG AB patients required less blood transfusions as compared to the other blood groups, especially in case of emergency operations. However, BG AB patients also had a higher mortality which was due to secondary cardiovascular complications. The impact of blood type on the rate of cardiovascular mortality was confirmed in the logistic regression model. BG AB patients have a worse outcome after CABG surgery due to an increased incidence of fatal cardiovascular complications. As perioperative myocardial ischemia due to graft occlusion appears to be the most likely explanation, stricter anticoagulation for BG AB patients should be discussed.
- 1 March 2022
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 31 (3) , 407-414
Comparison of Perioperative High-Sensitive Troponin T and Troponin I Assays in Cardiac Surgery
- 1 March 2022
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 31 (3) , 407-414
Comparison of Perioperative High-Sensitive Troponin T and Troponin I Assays in Cardiac Surgery
- Open Access
- 16 August 2017
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 52 (5) , 881-887
The German Aortic Valve Score II
The German Aortic Valve Score (GAVS) was developed for national quality assurance regarding the in-hospital mortality rate of patients following isolated aortic valve replacement. The goal of this work was the recalibration of the GAVS in the context of increased numbers of transcatheter aortic valve implantations. In 2011 and 2012, 36 183 cases were documented who had either surgical aortic valve replacement or transcatheter aortic valve implantation (45%). All cases were randomly assigned to the study or to the validation group. All items of the data set were checked for significance by developing a multiregression risk model using iterative backward elimination. Calibration was ascertained using the Hosmer–Lemeshow method. To define the quality of discrimination, the area under the receiver operating characteristic curve (C-statistic) was calculated. The randomized study cohort comprised 18 054 patients. After modelling with multiple regression algorithms, 18 of the initial 28 risk factors entered the risk model. When applied to the validation group, the newly developed GAVS II showed good calibration with a P-value of 0.411 in the Hosmer–Lemeshow test and good discrimination with a C-statistic of 0.741. The GAVS II is a new risk model that is applicable to cohorts having surgical aortic valve replacement or transcatheter aortic valve implantation procedures.
- 16 August 2017
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 52 (5) , 881-887
Open AccessThe German Aortic Valve Score II
The German Aortic Valve Score (GAVS) was developed for national quality assurance regarding the in-hospital mortality rate of patients following isolated aortic valve replacement. The goal of this work was the recalibration of the GAVS in the context of increased numbers of transcatheter aortic valve implantations. In 2011 and 2012, 36 183 cases were documented who had either surgical aortic valve replacement or transcatheter aortic valve implantation (45%). All cases were randomly assigned to the study or to the validation group. All items of the data set were checked for significance by developing a multiregression risk model using iterative backward elimination. Calibration was ascertained using the Hosmer–Lemeshow method. To define the quality of discrimination, the area under the receiver operating characteristic curve (C-statistic) was calculated. The randomized study cohort comprised 18 054 patients. After modelling with multiple regression algorithms, 18 of the initial 28 risk factors entered the risk model. When applied to the validation group, the newly developed GAVS II showed good calibration with a P-value of 0.411 in the Hosmer–Lemeshow test and good discrimination with a C-statistic of 0.741. The GAVS II is a new risk model that is applicable to cohorts having surgical aortic valve replacement or transcatheter aortic valve implantation procedures.
- 1 July 2013
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 146 (1) , 244-5
Reply to the editor.
- 1 July 2013
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 146 (1) , 244-5
Reply to the editor.
- 23 January 2013
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 61 (S 01) , OP14
Minimized use of contrast agent and fluoroscopic time by 3D echocardiography in transapical TAVI procedures
Objective: Fluoroscopy is the standard positioning and guiding method in TAVI procedures. From June 2008 to April 2010 our regime consisted of using fluoroscopic angiography with contrast medium during initial outlining of the aortic root, balloon valvuloplasty, for positioning of the prosthesis, optionally also for repositioning and for final control after implantation (group CP). From June 2010 we introduced a new protocol with the aid of 3D echocardiography (TEE) to minimize use of contrast agent and fluoroscopic time (group EP). Method: 84 consecutive patients were included in the analysis (CP: n = 28, EP: n = 56). Age and logistic EUROSCORE did not significantly differ between CP and EP (means 77.8 ± 0.6 years, 22.9 ± 1.8%). TEE was performed using the Philips iE33 ultrasound system with a Philips X7 – 2 t TEE-probe. All patients received an Edwards-Sapien transcatheter heart valve (ES-THV) via transapical approach. The cumulative dose of contrast agent and fluoroscopic time was compared between both groups. Patients treated with the new protocol (EP) regularely received only one dose of contrast agent just before the deployment of the prosthesis. Valvuloplasty, crude positioning of the valve and final control after deployment were performed using TEE and fluoroscopy without contrast agent. Continuous variables were given as mean with standard error in case of Gaussian distribution and median with interquartile range (IR) if not parametric. Differences were tested for with student's t or Mann-Whitney -U test. Results: Procedural success could be achieved in 95.3% with one intraoperative death and two conversions to open surgery. After implementation of the new implantation protocol median use of contrast agent could be reduced by 77% (p < 0.0001, mean values given 130 ± 16 ml vs. 30 ± 2.7 ml respectively), mean fluoroscopic time could be reduced by 28% (10.19 ± 0.8 min vs. 7.34 ± 0.3 min, p = 0.0001). Postoperative increase in creatinine was significantly higher in the CP group compared to the EP group (0.25 mg/dl, IR 0.15 – 0.58 vs. 0.12 mg/dl IR 0.01 – 0.47, p = 0.03). Conclusion: Changing the transapical implantation strategy to a 3D-TEE supported approach was accompanied by a significant decrease of both fluoroscopic time and use of contrast agent. Furthermore the EP group experienced less increase in postoperative creatinine. We therefore consider our approach as successful measure to preserve kidney function and reduce X-ray exposure for patients and personnel.
- 23 January 2013
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 61 (S 01) , OP14
Minimized use of contrast agent and fluoroscopic time by 3D echocardiography in transapical TAVI procedures
Objective: Fluoroscopy is the standard positioning and guiding method in TAVI procedures. From June 2008 to April 2010 our regime consisted of using fluoroscopic angiography with contrast medium during initial outlining of the aortic root, balloon valvuloplasty, for positioning of the prosthesis, optionally also for repositioning and for final control after implantation (group CP). From June 2010 we introduced a new protocol with the aid of 3D echocardiography (TEE) to minimize use of contrast agent and fluoroscopic time (group EP). Method: 84 consecutive patients were included in the analysis (CP: n = 28, EP: n = 56). Age and logistic EUROSCORE did not significantly differ between CP and EP (means 77.8 ± 0.6 years, 22.9 ± 1.8%). TEE was performed using the Philips iE33 ultrasound system with a Philips X7 – 2 t TEE-probe. All patients received an Edwards-Sapien transcatheter heart valve (ES-THV) via transapical approach. The cumulative dose of contrast agent and fluoroscopic time was compared between both groups. Patients treated with the new protocol (EP) regularely received only one dose of contrast agent just before the deployment of the prosthesis. Valvuloplasty, crude positioning of the valve and final control after deployment were performed using TEE and fluoroscopy without contrast agent. Continuous variables were given as mean with standard error in case of Gaussian distribution and median with interquartile range (IR) if not parametric. Differences were tested for with student's t or Mann-Whitney -U test. Results: Procedural success could be achieved in 95.3% with one intraoperative death and two conversions to open surgery. After implementation of the new implantation protocol median use of contrast agent could be reduced by 77% (p < 0.0001, mean values given 130 ± 16 ml vs. 30 ± 2.7 ml respectively), mean fluoroscopic time could be reduced by 28% (10.19 ± 0.8 min vs. 7.34 ± 0.3 min, p = 0.0001). Postoperative increase in creatinine was significantly higher in the CP group compared to the EP group (0.25 mg/dl, IR 0.15 – 0.58 vs. 0.12 mg/dl IR 0.01 – 0.47, p = 0.03). Conclusion: Changing the transapical implantation strategy to a 3D-TEE supported approach was accompanied by a significant decrease of both fluoroscopic time and use of contrast agent. Furthermore the EP group experienced less increase in postoperative creatinine. We therefore consider our approach as successful measure to preserve kidney function and reduce X-ray exposure for patients and personnel.
- 1 December 2012
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 144 (6) , 1527-1530
Open antegrade aortic stent implantation after surgical treatment in type A aortic dissection
- 1 December 2012
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 144 (6) , 1527-1530
Open antegrade aortic stent implantation after surgical treatment in type A aortic dissection
- Open Access
- 1 September 2009
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 13 (9b) , 3485-3496
Classically and alternatively activated macrophages contribute to tissue remodelling after myocardial infarction
An important goal in cardiology is to minimize myocardial necrosis and to support a discrete but resilient scar formation after myocardial infarction (MI). Macrophages are a type of cells that influence cardiac remodelling during MI. Therefore, the goal of the present study was to investigate their transcriptional profile and to identify the type of activation during scar tissue formation. Ligature of the left anterior descending coronary artery was performed in mice. Macrophages were isolated from infarcted tissue using magnetic cell sorting after 5 days. The total RNA of macrophages was subjected to microarray analysis and compared with RNA from MI and LV‐control. mRNA abundance of relevant targets was validated by quantitative real‐time PCR 2, 5 and 10 days after MI (qRT‐PCR). Immunohistochemistry was performed to localize activation type‐specific proteins. The genome scan revealed 68 targets predominantly expressed by macrophages after MI. Among these targets, an increased mRNA abundance of genes, involved in both the classically (tumour necrosis factor α, interleukin 6, interleukin 1β) and the alternatively (arginase 1 and 2, mannose receptor C type 1, chitinase 3‐like 3) activated phenotype of macrophages, was found 5 days after MI. This observation was confirmed by qRT‐PCR. Using immunohistochemistry, we confirmed that tumour necrosis factor α, representing the classical activation, is strongly transcribed early after ligature (2 days). It was decreased after 5 and 10 days. Five days after MI, we found a fundamental change towards alternative activation of macrophages with up‐regulation of arginase 1. Our results demonstrate that macrophages are differentially activated during different phases of scar tissue formation after MI. During the early inflammatory phase, macrophages are predominantly classically activated, whereas their phenotype changes during the important transition from inflammation to scar tissue formation into an alternatively activated type.
- 1 September 2009
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 13 (9b) , 3485-3496
Open AccessClassically and alternatively activated macrophages contribute to tissue remodelling after myocardial infarction
An important goal in cardiology is to minimize myocardial necrosis and to support a discrete but resilient scar formation after myocardial infarction (MI). Macrophages are a type of cells that influence cardiac remodelling during MI. Therefore, the goal of the present study was to investigate their transcriptional profile and to identify the type of activation during scar tissue formation. Ligature of the left anterior descending coronary artery was performed in mice. Macrophages were isolated from infarcted tissue using magnetic cell sorting after 5 days. The total RNA of macrophages was subjected to microarray analysis and compared with RNA from MI and LV‐control. mRNA abundance of relevant targets was validated by quantitative real‐time PCR 2, 5 and 10 days after MI (qRT‐PCR). Immunohistochemistry was performed to localize activation type‐specific proteins. The genome scan revealed 68 targets predominantly expressed by macrophages after MI. Among these targets, an increased mRNA abundance of genes, involved in both the classically (tumour necrosis factor α, interleukin 6, interleukin 1β) and the alternatively (arginase 1 and 2, mannose receptor C type 1, chitinase 3‐like 3) activated phenotype of macrophages, was found 5 days after MI. This observation was confirmed by qRT‐PCR. Using immunohistochemistry, we confirmed that tumour necrosis factor α, representing the classical activation, is strongly transcribed early after ligature (2 days). It was decreased after 5 and 10 days. Five days after MI, we found a fundamental change towards alternative activation of macrophages with up‐regulation of arginase 1. Our results demonstrate that macrophages are differentially activated during different phases of scar tissue formation after MI. During the early inflammatory phase, macrophages are predominantly classically activated, whereas their phenotype changes during the important transition from inflammation to scar tissue formation into an alternatively activated type.
- 1 February 2009
- Published by Elsevier in International Journal of Cardiology
- Vol. 132 (2) , e77-e79
Severe mitral regurgitation in Tako-Tsubo cardiomyopathy
- 1 February 2009
- Published by Elsevier in International Journal of Cardiology
- Vol. 132 (2) , e77-e79
Severe mitral regurgitation in Tako-Tsubo cardiomyopathy
- 1 November 2008
- Published by Elsevier in International Journal of Cardiology
- Vol. 130 (2) , 266-268
Sympathoadrenergic overstimulation in Tako-Tsubo cardiomyopathy triggered by physical and emotional stress
- 1 November 2008
- Published by Elsevier in International Journal of Cardiology
- Vol. 130 (2) , 266-268
Sympathoadrenergic overstimulation in Tako-Tsubo cardiomyopathy triggered by physical and emotional stress